INGN FY 2024 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$336M+6.4% YoY

Gross Profit

$155M46.1% margin

Operating Income

-$43M-12.7% margin

Net Income

-$36M-10.7% margin

EPS (Diluted)

$-1.52

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

-$11M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$296M

Total Liabilities

$122M

Stockholders' Equity

$174M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$336M	$316M	+6.4%
Gross Profit	$155M	$127M	+22.1%
Operating Income	-$43M	-$109M	+61.1%
Net Income	-$36M	-$102M	+65.0%